Video & Transcript Research : 'clinical trial'
Page 7 of 379
TX
Transcript Highlights:
- the rate in the vaccine ensure and sorry the vaccine insert is two point eight percent of those in clinical
- identified. a lack of clinical space as the most common reason for why a nursing program is unable to
- With the information outlined in this bill, schools without. efficient clinical training sites could
- Striking a balance and legislation where more data is accessible to assist in placements for clinical
- Between the cost of paying for an advanced degree and having. lower salaries than our clinical partners
Bills:
HB 1105, HB1527, HB1787, HB1972, HB2081, HB3296, HB3976, HB4071, HB4234, HB4438, HB4701, HB5092, HB5150, HB5180, HB5265, HB5333, HJR203
Keywords:
tuition exemption, paramedics, higher education, laboratory fees, emergency medical services, peace officers, criminal justice, law enforcement, degree programs, public institutions, HB 1787, HPV, human papillomavirus, college health, university health, student health, public health education, prevention program, screening, early detection
NH
New Hampshire 2026 Regular Session
Senate Health and Human Services (04/01/2026)
Health and Human Services
Transcript Highlights:
- </c><01:07:45.840><c> trials</c><01:07:46.240><c> in</c> China because doing clinical trials in China
- My understanding one of clinical trials.
- It appears not to clinical trials.
- trials to prove so important to clinical trials to prove effectiveness. effectiveness. effectiveness
- Had this the clinical trial process.
NM
New Mexico 2025 Regular Session
IC - Courts, Corrections and Justice Nov 7th, 2025
Courts, Corrections & Justice Committee
Transcript Highlights:
- They get a higher reimbursement rate than an outpatient clinic or clinic that does the same procedure
- , VA clinics, Indian Health Service clinics, and other rural and federally funded clinics.
- VA clinics are historically understaffed.
- I can tell you that my firm did a trial in May where it cost us over $600,000 to get to trial.
- These are people who work at the Mayo Clinic. or MD Anderson, and those clinical sites have privilege
TX
Texas 89th Regular
Senate Committee on Health and Human Services (Part II) May 7th, 2025
Health & Human Services
Transcript Highlights:
- Patients don't get to be a part of those clinical trials.
- So it wasn't a new drug, but the way it was put to the market didn’t follow typical clinical trials and
- If I want to participate in a clinical trial, I go to that place and say, "Put me in your trials."
- A lot of the next-gen vaccines are in standard clinical trials. Thank you, Madam Chair.
- practices or FDA regulations, and the clinical trials were out of school.
Bills:
HB18, HB37, HB116, HB18, HB37, HB116, HB388, HB879, HB913, HB1151, HB2216, HB2358, HB2809, SB577, SB1590, SB1782, SB1887, SB2744
Keywords:
HB 18, Texas Legislature, quorum break, quorum-busting, legislative walkout, absent legislators, political contributions, campaign finance, political expenditures, legislative caucus, specific-purpose committee, Texas Ethics Commission, civil penalty, show cause order, district court, Fifteenth Court of Appeals, session fundraising, travel lodging food expenses, legislative session, compelled attendance
OK
Oklahoma 2026 Regular Session
Criminal Judiciary REVISION 2: SB1379 - Removed Mar 31st, 2026 at 03:00 pm
Criminal Judiciary
Bills:
SB137, SB1216, SB1226, SB1238, SB1255, SB1256, SB1258, SB1325, SB1460, SB1543, SB1730, SB1733, SB1921
Keywords:
electronic monitoring, Department of Corrections, criminal justice, rehabilitation, public safety, SB 1216, drug court, drug courts, Oklahoma drug court, eligibility, substance abuse treatment, addiction, diversion program, criminal justice reform, probation violation, revocation, intermediate revocation facility, plea agreement, speedy trial waiver, preliminary hearing waiver
AL
Transcript Highlights:
- defer to the judge on this, but I think that they sat in the county jail for two years waiting for trial
- There were seven other women behind her sharing their stories in court during his trial, and he got 15
- During his trial, he got 15 years, but he only served two years. I just found that out this week.
- This bill is, members, this is what we've deemed the Speedy Trial Act.
- If you look on line 89, the Speedy Trial Fund is created by the state treasury.
Keywords:
criminal procedure, split sentencing, probation, Class A felony, Class B felony, minimum confinement, custodial sexual misconduct, sexual misconduct, inmate abuse, prisoner exploitation, correctional staff, jail staff, detention center, probation officer, parole officer, Department of Corrections, Department of Youth Services, sheriff, county jail, municipal jail
MO
Missouri 2026 Regular Session
Emerging Issues Feb 16th, 2026
Emerging Issues and Professional Registration
Transcript Highlights:
- The grants authorized by this bill are strictly for certified clinical drug development trials overseen
- So I've worked on clinical trials, mostly psilocybin, since 2022.
- To date, there are 86 completed clinical trials with psilocybin showing safety and efficacy.
- There are 163 clinical trials either pre-recruiting, recruiting, or ongoing for psilocybin.
- Additionally, in recent randomized clinical trials...
Summary:
The committee first met in executive session and voted do pass on House Bill 3037, House Bill 2760, House Bill 1778, and House Bill 2830, each by recorded roll call. HB 3037, HB 2760, and HB 1778 all passed 8-4, while HB 2830 passed unanimously 12-0. The committee also said it would not take up HB 1746 and HB 1769 yet, because more work was needed on an amendment.
The public hearing began with House Bill 3005, sponsored by Representative Justice, which would require public and school libraries to adopt and post reconsideration policies for challenged materials, limit requests to local residents or parents/guardians, extend the process to digital materials, and prohibit tracking or retaining personalized user data from digital library resources. Justice said the bill was developed with the Secretary of State’s office and library groups and was intended to add transparency, local control, and privacy protections. Testimony from EBSCO Information Services and the Missouri Library Association supported the bill as a codification of existing library practices and a way to create clearer procedures.
The committee then heard a group of similar bills on AI-generated or digitally altered depictions, including measures by Representatives Lucas, Farnan, Gallick, Schmidt, Williams, Houseman, and Dolan. The sponsors described the bills as closing loopholes in child pornography, revenge-porn, and digital impersonation laws, creating civil remedies, criminal penalties, and in some versions platform takedown requirements for nonconsensual altered images. Members raised questions about how to combine the bills, whether sunsets should be included, and how the proposals relate to existing revenge-porn law. No votes were taken on these bills during the hearing.
Finally, the committee heard House Bills 2817 and 2961 on ibogaine research for veterans and other trauma-affected populations, followed by House Bills 1717 and 1643 on psilocybin and other alternative therapies. Supporters, including veterans, first responders, clinicians, and family members, described severe PTSD, TBI, addiction, and suicide crises and said these treatments had helped them when conventional care had not. Opponents, including the Missouri State Medical Association, said they did not support non-FDA-approved drugs. Members questioned the cost and structure of the proposed studies, the role of the FDA, and whether similar research is already underway. The hearing ended without a vote on these bills.
AZ
Arizona 2026 Regular Session
03/11/2026 - Senate Health and Human Services
Senate Health and Human Services COR
Transcript Highlights:
- trial.
- I continued with the clinical trial of lecanemab, Leqembi.
- Not everyone can be in a clinical trial.
- actually stand trial.
- They are not competent to stand trial.
Summary:
The committee approved minutes from February 18, February 19, and March 4, then took up several health-related bills. HB 2050, which updates radiologic technologist and radiologic assistant standards, school accreditation, clinical hours, supervision rules, fees, and telehealth definitions, received support from a radiologic technologist and a nurse practitioner and passed 7-0 with a do-pass recommendation. HB 2082, creating a Childhood Cancer and Rare Childhood Disease Research Commission and expanding the research fund, was amended to require at least $5 million in funding before commission allocations and to shift grant-awarding authority to the DHS director; it passed 7-0 as amended, though members raised concerns about oversight. HB 2176, which changes DHS licensing denial criteria and complaint-investigation procedures for health care institutions, also passed 7-0 after testimony from hospital and public health representatives supporting clearer timelines and transparency, with one member noting concerns about possible subjectivity in ownership-related denials.
HB 2195, addressing DHS oversight of nursing care institutions, including personnel record access, deficiency timelines, and complaint-investigation deadlines, was amended to delay implementation until July 1, 2027 and allow off-site preliminary reviews; it passed 7-0 as amended, though one member said DHS should have been present to answer questions. HB 2202, appropriating $300,000 annually for a dementia care tele-mentoring program, drew support from the Alzheimer’s Association and a patient with younger-onset Alzheimer’s; it passed 6-1, with one no vote arguing medical schools should teach the material instead of the state funding it. HB 2307, an emergency measure to address placement of dangerous, incompetent, non-restorable defendants, was heavily debated and amended to use up to three beds at the Arizona State Hospital forensic campus temporarily, create a study committee, and sunset after five years; counties and DHS disagreed over whether counties should bear any costs, and the bill passed 4-3 as amended.
Finally, HB 2584, which prohibits public funds from being used for genetic sequencing equipment or services tied to foreign adversaries, passed 4-3 after a sponsor and a national security witness argued it would protect genomic data from hostile foreign control. The committee then adjourned.
TX
Texas 89th Regular
Trade, Workforce & Economic Development May 14th, 2025
Trade, Workforce & Economic Development
Transcript Highlights:
- And third, the ability of Texans with cancer to access clinical trials that are often multi-state and
- require access to their genomic data, especially when many clinical trials are their absolute.
- If they don't consent or gift out their entire DNA, they are going to miss out on a lot of clinical trials
- trials.
- And again, I'm just going to add, in case this is when it's involving clinical trials and cancer research
Keywords:
DNA privacy, genetic privacy, genetic testing, genetic material, DNA ownership, property right in DNA, genetic consent, biological sample, genomics, genetic data, HIPAA, health information privacy, health care provider, research ethics, human subjects research, law enforcement DNA, forensic DNA, paternity testing, medical examiner, genetic discrimination
HI
Hawaii 2025 Regular Session
HLT/HSH Joint Public Hearing - Fri Jan 31, 2025 @ 9:00 AM HST
Transcript Highlights:
- considering a clinical trial.
- considering a clinical trial.
- considering a clinical trial.
- considering a clinical trial.
- considering a clinical trial.
Summary:
The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously.
For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees.
The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.
NM
Transcript Highlights:
- We hired him to teach in the clinic.
- justice clinic, our natural resources and environmental law clinic, and our southwest Indian law We
- I did the full-year Advanced Clinic. I did my clinic in Indian law, believe it or not.
- That's the two legal writing clinics. We hired one person to teach in the clinic.
- That's the two legal writing clinics. We hired one person to teach in the clinic.
Keywords:
interstate medical licensure compact, physician licensure, medical license reciprocity, expedited licensure, medical practice act, New Mexico medical board, compact commission, physician mobility, telemedicine, license portability, background check, disciplinary action, joint investigation, reproductive health care, gender-affirming care, scope of practice, medical board transparency, multistate compact, licensure renewal, health care workforce
NM
New Mexico 2025 Regular Session
IC - Legislative Health and Human Services Oct 6th, 2025
Legislative Health & Human Services Committee
Transcript Highlights:
- We are charged with being a discovery science engine and translating that into clinical trials.
- We will have expert radiation oncologists to work with that and offer clinical trials. of Diagnostics
- One of our highest accruers into clinical trials.
- We do have that agreement with the tribes for, again, specifically clinical trials.
- The clinic we are looking at will be one of our education clinics.
NH
New Hampshire 2025 Regular Session
House Health, Human Services and Elderly Affairs (03/05/2025)
Health, Human Services & Elderly Affairs
Transcript Highlights:
- trials because those clinical trials are just too small.
- trials because those clinical trials are just too small.
- trials because those clinical trials are just too small.
- trials because those clinical trials are just too small.
- ><04:16:16.960><c> clinical</c> clinical trial there is no clinical clinical trial there is no clinical
MN
Minnesota 2025-2026 Regular Session
House Higher Education Finance and Policy Committee 3/5/26
Higher Education Finance and Policy
Transcript Highlights:
- where faculty can teach, train, conduct research, and run clinical trials.
- Clinical trials that advance medicine happen in our system. trials. Fairview is that platform.
- </c><00:37:04.240><c> Clinical</c><00:37:04.640><c> trials</c> Research that drives discovery happens
- and at Allina and at CentraCare, where we do clinical trials all over the place and all over the state
- </c><01:25:23.520><c> work</c> the clinical trials all of that work the clinical trials all of that work
TX
Transcript Highlights:
- SIPRT allows for more clinical trials, the creation of new companies and further prevention of cancer
- on that and I don't know of any current clinical trials in dementia that are looking your body heating
- This has led to long wait lists for both clinic visits and clinical trial participation.
- We run a clinical research institute where we do clinical trials.
- But there are clinical trials right now, it's not.
AR
Arkansas 2026 Regular Session
PUBLIC HEALTH- HOUSE HEALTH SERVICES SUBCOMMITTEE Jun 25th, 2026
Transcript Highlights:
- competent or fit to stand trial.
- competent or fit to stand trial.
- And so some of the clinics that we have that are behavioral health clinics, they have a... ...I don't
- they can stand trial.
- they can stand trial.
Summary:
The House Health Services Subcommittee met to approve the October 7, 2024 minutes and then shifted to a broad discussion of behavioral health policy, taking up work previously handled by a behavioral health working group. Representatives Wooldridge and Vaught described major gaps in Arkansas behavioral health care, emphasizing access problems, workforce shortages, rural service barriers, low reimbursement, and the need to move from a reactive crisis system to more proactive community-based care. Members discussed possible 2027-session priorities such as reducing red tape, improving provider licensing and supervision pathways, expanding billing codes and reimbursement structures, and considering interstate compacts and other workforce fixes.
A major focus was the state’s crisis and forensic system, including long waits for competency evaluations, the backlog at the Arkansas State Hospital, and the use of county jails for people awaiting treatment. DHS Director Paula Stone explained that Medicaid pays for most behavioral health services, but cannot pay for services in jails or state hospitals because those individuals are treated as inmates of public institutions, leaving state general revenue to cover much of that cost. She outlined DHS efforts including secured restoration beds, therapeutic communities, community mental health center contracts for jail-based services, and plans for an institution-for-mental-disease waiver that could allow Medicaid payment for certain hospital-based services.
Members also discussed crisis stabilization units, with DHS noting that Fort Smith and Jonesboro have been more successful than Fayetteville and Little Rock, largely because of location, partnerships, and law enforcement coordination. Questions covered reimbursement for county jails, step-down facilities, civil commitment options, non-emergency behavioral health transportation, and whether DHS should create a bed-availability dashboard similar to hospital systems. DHS said it does not currently have such a dashboard but is exploring the idea. The meeting ended with a commitment to continue the work, with more detailed discussion planned for August, and the subcommittee adjourned.
HI
Hawaii 2025 Regular Session
HHS, HHS DEFER, HHS DEFER, HHS DEFER, HHS-HRE Public Hearings 02-12-2025
Transcript Highlights:
- ><c> and</c> in clinical trials providing rapid and in clinical trials providing rapid and long-lasting
- I am currently involved in a clinical trial here in Hawaii looking at a psilocybin-like drug, and I think
- I am currently involved in a clinical trial here in Hawaii looking at a psilocybin-like drug, and I think
- </c><00:54:21.400><c> trial</c><00:54:21.839><c> here</c><00:54:22.359><c> in</c> involved in a clinical
- trial here in involved in a clinical trial here in Hawaii<00:54:23.000><c> looking</c><00:54:23.200>
Summary:
The Health and Human Services Committee heard testimony on several measures related to child welfare, health care access, overdose response, disability services, and waste management. For SB 710 on child welfare, the Department of Human Services, the Office of Wellness and Resilience, the Attorney General’s office, and multiple advocacy groups testified in support, with the Governor’s office noting support but deferring to the Attorney General on implementation because of separation-of-powers concerns. For SB 952 on child welfare services, DHS, the Governor’s office, and child- and trauma-informed care advocates supported the bill, saying it would help families access services, provide basic material support, and reduce strain on the child welfare system. SB 954 on a home health services rate study also drew support, including from DHS, the Hawaii Healthcare Association, and a public testifier who said the study would help ensure funds reach low-income, disabled, and kupuna recipients. SB 957 on overdose prevention received support from the Department of Health and the Attorney General, who said overdose prevention centers are evidence-based but raised federal-law concerns and recommended amendments; the Hawaii Health and Harm Reduction Center and others also testified in support.
The committee then moved to the 1:00 regular calendar and heard SB 850 on disability health disparity, which was supported by the Executive Office on Aging, the Hawaii State Council on Developmental Disabilities, the Hawaii Disability Rights Center, self-advocates, and others. Testimony emphasized that a disparity study could improve workforce development, training, and services for people with disabilities. SB 838 on continuous glucose monitoring drew support from health agencies and advocates, with testimony stressing that monitors can be critical for some diabetes patients. SB 829 on health care was supported by the Department of Health and health care stakeholders, who said it would help rotating physicians serve neighbor islands without local hospital privileges and align with CMS rules. SB 446 on waste management drew mixed testimony: the Department of Health and several public entities provided comments, the County of Maui opposed, and environmental advocates urged stronger aquifer protections and limits on ash reuse.
During decision making, the committee adopted recommendations to pass SB 298, SB 322, SB 299, SB 450, SB 451, SB 949, SB 710, SB 957, SB 69, and SD 952 with various amendments, including technical changes, blank appropriations, and defective dates. SB 323, SB 324, SB 712, SB 950, SB 954, and SB 959 were deferred, largely because companion House measures were moving or similar Senate measures had already passed. The chair also announced recesses to find quorum and noted that some bills from the earlier Monday calendar were being deferred to avoid duplication.
KY
Kentucky 2025 Regular Session
Interim Joint Committee on Health Services (9-16-25)
Transcript Highlights:
- We're clinical trials that is underway.
- trials, but we are also in the future hoping to explore clinical trials for other areas of interest,
- </c> future um hoping to explore um clinical future um hoping to explore um clinical trials<01:36:54.400
- Our clinical trials were delayed because of drug supply, and so those are just the cancer trial launched
- </c> license to do careful clinical trials. license to do careful clinical trials.
Summary:
The committee met and approved the minutes from its August 27 meeting. It then received a presentation from Katherine Castanza of the National Conference of State Legislators on the Medicaid provisions in the 2025 budget reconciliation bill, referred to as HR1. She explained that the bill is estimated by CBO to save the federal government $911 billion over 10 years, with more than 20 Medicaid-specific provisions, most of the savings concentrated in five policies and largely backloaded into 2030-2034. She emphasized that the bill’s effects will vary by state, but that expansion states and hospitals are expected to be most affected, in part because of changes to eligibility, provider taxes, and state-directed payments.
Castanza highlighted several new funding and flexibility provisions, including a $50 billion Rural Health Transformation Fund for 2026-2030 and a new home- and community-based services waiver option effective July 1, 2028, with $100 million in grants in fiscal year 2027. She also outlined major eligibility changes for Medicaid expansion adults: work or community engagement requirements effective January 1, 2027; twice-yearly redeterminations for the expansion population effective the same date; and new cost sharing for certain expansion adults effective October 1, 2028. She noted that Kentucky, as an expansion state, would be subject to these changes and that state agencies would face significant implementation demands, especially because federal guidance and timelines are tight.
A substantial portion of the presentation focused on financing changes. Castanza described new limits on provider taxes, including a 0% safe harbor for new taxes and a phased reduction for existing taxes in expansion states beginning in 2028, while nursing facilities and intermediate care facilities are exempt from the reduction if already taxed. She also explained that state-directed payments will be capped and phased down over time, with existing arrangements grandfathered only briefly; she said Kentucky has 11 approved state-directed payments and could see significant fiscal effects. She added that the bill also bars Medicaid payments to Planned Parenthood or similarly situated providers for one year, changes immigrant eligibility rules effective October 1, 2026, lowers the federal match for certain emergency services, and expands the scope of the federal erroneous payment recoupment provision effective October 1, 2029. Throughout, she stressed that federal savings may translate into state cost shifts and that implementation timing will be critical.
CA
Transcript Highlights:
- The University of California system already has federally registered clinical trials underway at campuses
- I currently lead a portfolio of six phase three and two phase two clinical trials, and I see patients
- including UCSF, federally registered clinical trials underway at campuses including U.S.F, U.C.
- I currently lead a portfolio of six phase three and two phase two clinical trials, and I see patients
- in our department's advantage. six phase three and two phase two clinical trials, and I see patients
KY
Kentucky 2025 Regular Session
Make America Healthy Again Kentucky Task Force (8-20-25)
Transcript Highlights:
- </c> standard science usually human clinical standard science usually human clinical trials<00:05:02.639
- </c><00:05:06.320><c> intermediate</c> clinical trials to assess intermediate clinical trials to assess
- </c> sweeteners, randomized control clinical sweeteners, randomized control clinical trials,<00:10:06.160
- <c> showing</c> 50 clinical trials, they're all showing 50 clinical trials, they're all showing the<00
- </c> So interestingly um a large clinical So interestingly um a large clinical trial<00:29:01.120><c>
Summary:
The task force met for its third meeting, approved the minutes, and heard testimony from Dr. Jack on behalf of the American Beverage Association and Kentucky Beverage Association. Dr. Jack argued that the “totality of the science” supports low- and no-calorie sweeteners as safe and useful tools for reducing sugar and calories, citing FDA and other domestic and international reviews, clinical trials, and the FDA’s recent healthy-label rule. He also described the industry’s transparency efforts, including a “Good to Know” database compiling ingredient and safety information, and said the beverage industry has voluntarily worked to offer more choices with less sugar.
Members questioned him about whether beverage ingredients are restricted in other countries, possible health effects beyond weight and cancer, concerns about metabolic issues and gut microbiome effects, whether sweeteners are addictive, and why companies do not simply remove sweeteners. Dr. Jack responded that most ingredients are permitted in many jurisdictions, that broad food-safety reviews have looked at multiple endpoints and found the ingredients safe, that the gut microbiome is still being studied, and that recent clinical evidence does not show increased sweetness preference. He also said business decisions about formulations are up to companies and noted that cane sugar and high-fructose corn syrup are metabolically similar.
The committee also discussed consumer apps and ingredient-scoring tools; Dr. Jack said the industry’s website presents facts without interpretation and is based on food-safety agency assessments. At the end of his testimony, the chair accepted additional fact sheets for the committee. The meeting then moved on to introduce Dr. Gary Huber, who began testimony by emphasizing integrative medicine, metabolic syndrome, and the role of diet, exercise, sleep, and stress in health, but his full presentation was not included in the excerpt.